*Department of Electrical and Computer Engineering, Michigan Technological University, Houghton, MI;
†Rocky Mountain Lions Eye Bank, Aurora, CO; and
‡Cornea Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD.
Correspondence: Allen O. Eghrari, MD, MPH, Department of Ophthalmology, Wilmer Eye Institute at Johns Hopkins, 1800 Orleans St, Woods 375, Baltimore, MD 21287 (e-mail: [email protected]).
The authors have no relevant financial conflicts of interest to disclose that would potentially influence the results or interpretation of this study. A. O. Eghrari has equity in Treyetech and LuckyVision. A. O. Eghrari was supported by National Institutes of Health L30 EY024746. R. Karmakar and A. O. Eghrari were supported by National Science Foundation Grant 2143608.
Authors' contributions: R. Karmakar, S. Nooshabadi, J. Lohmeier, S. Terrin, and A. O. Eghrari designed the study. R. Karmakar and A. O. Eghrari analyzed and interpreted the data. All authors read and approved the final manuscript.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.corneajrnl.com).
Ethics approval and consent to participate: The data set composed of deidentified data from deceased individuals and was therefore waived from institutional research board approval.
Availability of data and material: The data sets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.
